eLife Assessment: Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopeniaYongliang Yang(Dalian University of Technology)UnknownFebruary 14, 202410.7554/elife.94765.1.sa2Cited by 0SaveCiteExport RISWatch citationsRelated PapersPhosphorylation of 17β-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice|Nature Communications|2022|50Highly Selective NIR Probe for Intestinal β-Glucuronidase and High-Throughput Screening Inhibitors to Therapy Intestinal Damage|ACS Sensors|2018|48